A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
复制标题
DOI:
10.1093/europace/euad320
复制
发表时间:
2023-11-02
期刊:
影响因子:
6.1
通讯作者:
Gudmundsdottir, Valborg
中科院分区:
文献类型:
--
作者:
Jonmundsson, Thorarinn;Steindorsdottir, Anna E.;Austin, Thomas R.;Frick, Elisabet A.;Axelsson, Gisli T.;Launer, Lenore;Psaty, Bruce M.;Loureiro, Joseph;Orth, Anthony P.;Aspelund, Thor;Emilsson, Valur;Floyd, James S.;Jennings, Lori;Gudnason, Vilmundur;Gudmundsdottir, Valborg
Atrial fibrillation (AF) is associated with high risk of comorbidities and mortality. Our aim was to examine causal and predictive relationships between 4137 serum proteins and incident AF in the prospective population-based Age, Gene/Environment Susceptibility-Reykjavik (AGES-Reykjavik) study. The study included 4765 participants, of whom 1172 developed AF. Cox proportional hazards regression models were fitted for 4137 baseline protein measurements adjusting for known risk factors. Protein associations were tested for replication in the Cardiovascular Health Study (CHS). Causal relationships were examined in a bidirectional, two-sample Mendelian randomization analysis. The time-dependent area under the receiver operating characteristic curve (AUC)-statistic was examined as protein levels and an AF-polygenic risk score (PRS) were added to clinical risk models. The proteomic signature of incident AF consisted of 76 proteins, of which 63 (83%) were novel and 29 (38%) were replicated in CHS. The signature included both N-terminal prohormone of brain natriuretic peptide (NT-proBNP)-dependent (e.g. CHST15, ATP1B1, and SVEP1) and independent components (e.g. ASPN, AKR1B, and LAMA1/LAMB1/LAMC1). Nine causal candidates were identified (TAGLN, WARS, CHST15, CHMP3, COL15A1, DUSP13, MANBA, QSOX2, and SRL). The reverse causal analysis suggested that most AF-associated proteins were affected by the genetic liability to AF. N-terminal prohormone of brain natriuretic peptide improved the prediction of incident AF events close to baseline with further improvements gained by the AF-PRS at all time points. The AF proteomic signature includes biologically relevant proteins, some of which may be causal. It mainly reflects an NT-proBNP-dependent consequence of the genetic liability to AF. N-terminal prohormone of brain natriuretic peptide is a promising marker for incident AF in the short term, but risk assessment incorporating a PRS may improve long-term risk assessment. AGES-RS, Age, Gene/Environment Susceptibility-Reykjavik study; MR, Mendelian randomization; AF, atrial fibrillation; CHS, Cardiovascular Health Study; PRS, polygenic risk score.
登录
查看更多内容
影响因子:
37.8
作者:
Huxley RR;Lopez FL;Folsom AR;Agarwal SK;Loehr LR;Soliman EZ;Maclehose R;Konety S;Alonso A
通讯作者:
Alonso A
影响因子:
2.1
作者:
Bowden J;Davey Smith G;Haycock PC;Burgess S
通讯作者:
Burgess S
影响因子:
17.1
作者:
Finan C;Gaulton A;Kruger FA;Lumbers RT;Shah T;Engmann J;Galver L;Kelley R;Karlsson A;Santos R;Overington JP;Hingorani AD;Casas JP
通讯作者:
Casas JP
影响因子:
2.1
作者:
Gkatzionis A;Burgess S;Newcombe PJ
通讯作者:
Newcombe PJ
影响因子:
37.8
作者:
Chung, MK;Martin, DO;Van Wagoner, DR
通讯作者:
Van Wagoner, DR